HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ki Yong Lee Selected Research

Scopolamine (Hyoscine)

11/2012Cognition-enhancing and neuroprotective activities of the standardized extract of Betula platyphylla bark and its major diarylheptanoids.
5/2009Cognitive-enhancing activity of loganin isolated from Cornus officinalis in scopolamine-induced amnesic mice.
1/2009KD-501, a standardized extract of Scrophularia buergeriana has both cognitive-enhancing and antioxidant activities in mice given scopolamine.
6/2008Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice.
1/2006Acteoside of Callicarpa dichotoma attenuates scopolamine-induced memory impairments.
2/2005ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, significantly improved scopolamine-induced memory impairment in mice.
1/2005Anti-acetylcholinesterase and anti-amnesic activities of a pregnane glycoside, cynatroside B, from Cynanchum atratum.
7/2003Anti-amnestic activity of E-p-methoxycinnamic acid from Scrophularia buergeriana.
1/2003Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Ki Yong Lee Research Topics

Disease

8Body Weight (Weight, Body)
11/2012 - 01/2003
6Alzheimer Disease (Alzheimer's Disease)
03/2013 - 01/2005
5Stroke (Strokes)
01/2014 - 02/2005
5Amnesia (Dissociative Amnesia)
11/2012 - 01/2003
4Neurodegenerative Diseases (Neurodegenerative Disease)
03/2013 - 02/2005
4Memory Disorders (Memory Loss)
11/2012 - 02/2005
2Ischemia
01/2014 - 06/2012
1Fibrosis (Cirrhosis)
06/2015
1Fatty Liver
06/2015
1Liver Cirrhosis (Hepatic Cirrhosis)
06/2015
1Hyperlipidemias (Hyperlipidemia)
06/2015
1Parkinson Disease (Parkinson's Disease)
07/2013
1Yin Deficiency (Yinxu)
03/2013
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2013
1Cerebral Infarction
06/2012
1Brain Ischemia (Cerebral Ischemia)
06/2012
1Nervous System Diseases (Neurological Disorders)
03/2009
1Neoplasms (Cancer)
08/2006
1Neuroblastoma
04/2006

Drug/Important Bio-Agent (IBA)

9Scopolamine (Hyoscine)FDA Link
11/2012 - 01/2003
2asiatic acidIBA
01/2014 - 06/2012
2AcetylcholinesteraseIBA
05/2009 - 06/2008
1Protein Kinases (Protein Kinase)IBA
06/2015
1Collagen Type I (Type I Collagen)IBA
06/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
06/2015
1geniposideIBA
06/2015
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2014
1Apoptosis Inducing FactorIBA
01/2014
1Carbon MonoxideIBA
01/2014
1Cytochromes c (Cytochrome c)IBA
01/2014
1Dopamine (Intropin)FDA LinkGeneric
07/2013
1dibenzocyclooctadieneIBA
03/2013
1LignansIBA
03/2013
1CarnosineIBA
01/2013
1DiarylheptanoidsIBA
11/2012
1Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2012
1FlavonoidsIBA
06/2012
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2012
1loganinIBA
05/2009
1calpain inhibitorsIBA
03/2009
1mu-calpainIBA
03/2009
1donepezil (Aricept)FDA LinkGeneric
06/2008
1harpagosideIBA
06/2008
1lavendustin AIBA
08/2006
1GlycosidesIBA
04/2006
1acteosideIBA
01/2006
1ESP 102IBA
02/2005
1cynatroside BIBA
01/2005
1coumarinIBA
01/2003
1decursinIBA
01/2003

Therapy/Procedure

1Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2013
1Oral Administration
01/2009